[
    [
        {
            "time": "2023-03-24",
            "original_text": "达成全年物业合同销售目标 中国奥园年度净利大增78%至52.2亿元",
            "features": {
                "keywords": [
                    "中国奥园",
                    "物业合同",
                    "销售目标",
                    "净利增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "房地产"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "达成全年物业合同销售目标 中国奥园年度净利大增78%至52.2亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-24",
            "original_text": "白云山(00874)子公司收到蛇胆陈皮散和蛇胆川贝散的药品补充申请批件",
            "features": {
                "keywords": [
                    "白云山",
                    "蛇胆陈皮散",
                    "蛇胆川贝散",
                    "药品补充申请"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山(00874)子公司收到蛇胆陈皮散和蛇胆川贝散的药品补充申请批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-24",
            "original_text": "白云山(00874)附属注射用克林霉素磷酸酯获药品注册批件 主治细菌感染",
            "features": {
                "keywords": [
                    "白云山",
                    "克林霉素磷酸酯",
                    "药品注册",
                    "细菌感染"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山(00874)附属注射用克林霉素磷酸酯获药品注册批件 主治细菌感染",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-24",
            "original_text": "白云山(00874)：星群药业获麦精鱼肝油等6个药品《药品再注册批件》",
            "features": {
                "keywords": [
                    "白云山",
                    "星群药业",
                    "麦精鱼肝油",
                    "药品再注册"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山(00874)：星群药业获麦精鱼肝油等6个药品《药品再注册批件》",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-24",
            "original_text": "白云山(00874.HK)：奇星药业收到药品补充申请批件",
            "features": {
                "keywords": [
                    "白云山",
                    "奇星药业",
                    "药品补充申请"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白云山(00874.HK)：奇星药业收到药品补充申请批件",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]